A Study of the Effect of Concomitant Administration of Multiple Doses of BMS-708163 on the Pharmacokinetics of Galantamine in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 19 Jul 2012
At a glance
- Drugs Avagacestat (Primary) ; Galantamine (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- 21 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 15 Apr 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.